Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphire Energy developed and demonstrated a proprietary biotechnology platform to produce renewable "Green Crude" oil from algae at commercial scale. The company operated the world's first commercial demonstration algae-to-energy facility and produced barrels of crude oil year-round. It raised over $426 million in funding but ultimately sold its assets; it is no longer active as an independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphire Energy.